Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of α2-macroglobulin into human nasal airways

Clinical and Experimental Allergy

Volumn 27, Issue 4, 1997, Pages 438-444

  Greiff, L ^a   Andersson, M ^a   Svensson, C ^a   Persson, C G A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; Antihistamine; Rhinitis

Indexed keywords

ALPHA 2 MACROGLOBULIN; AZELASTINE; CETIRIZINE; HISTAMINE; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; INTRANASAL DRUG ADMINISTRATION; LAVAGE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030932697     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00730.x     Document Type: Article

References (13)

1. Weiler JM, Meltzer EO, Benson PM et al. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model. J Allergy Clin Immunol 1994; 94:972-80.
2. Thomas KE, Ollier S, Ferguson H, Davies RJ. The effect of intranasal azelastine, Rhinolast®, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen. Clin Exp Allergy 1992; 22:642-7.
3. Svensson C, Baumgarten CR, Pipkorn U, Alkner U, Persson CGA. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax 1989; 44: 13-18.
4. Greiff L, Pipkorn U, Alkner U, Persson CGA. The 'nasal pool-device' applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/ secretions. Clin Exp Allergy 1990; 20:253-9.
5. Greiff L, Andersson M, Svensson C, Alkner U, Persson CGA. Glucocorticoids may not inhibit plasma exudation by direct vascular affects in human airways.Eur Resp J 1994; 7:1120-4.
6. 1-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol 1988; 82:881-7.
7. 1 antihistamine. inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990; 142:167-71.
8. 2-macroglobulin and tryptase in allergic rhinitis. J Allergy Clin Immunol 1995; 96:97-103.
9. Svensson C, Andersson M, Greiff L, Alkner U, Persson CGA. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 1995; 25:942-50.
10. Svensjö E, Joyner WL. The effects of intermittent and continuous stimulation of microvessels in the cheek pouch of hamsters with histamine and bradykinin on the development of leaky sites. Microvasc Endothel Lymph 1984; 1:381-96.
11. Majno G, Palade GE, Schoefl GI. Studies on inflammation II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol 1961; 11:607-26.
12. Persson CGA, Andersson M, Greiff L et al. Airway permeability. Clin Exp Allergy 1995; 23:807-14.
13. Grega GJ, Persson CGA, Svensjö E. Endothelial cell reactions to inflammatory mediators assessed by fluid and solute flux analysis. In: Ryan US, ed. Endothelial cells. Boca Raton: CRC Press, 1988:103-19.